about
Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction.Electronic patient record and archive of records in Cardio.net system for telecardiology.KARDIONET: telecardiology based on GRID technology.Assessment of CHADS2 and CHA 2DS 2-VASc scores in obstructive sleep apnea patients with atrial fibrillation.OSACS score-a new simple tool for identifying high risk for Obstructive Sleep Apnea Syndrome based on clinical parameters.Prevalence of depressive disorders in professional drivers - epidemiologic subanalysis of the RACER study.Neuropsychological and neurological sequelae of out-of-hospital cardiac arrest and the estimated need for neurorehabilitation: a prospective pilot study.The incidence of asymptomatic paroxysmal atrial fibrillation in patients treated with propranolol or propafenone.Usefulness of the SAME-TT2R2 score to predict anticoagulation control on VKA in patients with atrial fibrillation and obstructive sleep apnea.Stratification of cardiovascular risk in patients with atrial fibrillation and obstructive sleep apnea-validity of the 2MACE score.Myocardial infarction type 4b in human immunodeficiency virus-infected patient.Obstructive sleep apnoea in patients with atrial fibrillation: prevalence, determinants and clinical characteristics of patients in Polish population.Long QT interval in a patient after out-of-hospital cardiac arrest with hypocalcaemia, undergoing therapeutic hypothermia.[Hyperthyroidism after iodine-containing contrast agent administration].Complication of acute myocardial infarction by systemic arterial embolism in the era of multimodality imaging.[Should cardiologist routinely screen and evaluate patients for sleep disordered breathing?].Usefulness of the D-dimer concentration as a predictor of mortality in patients with out-of-hospital cardiac arrest.Does time delay between the primary cardiac arrest and PCI affect outcome?[Patient with stable ischaemic heart disease and essential thrombocythemia in Invasive Cardiology Laboratory -- role of the automated systems for estimation of platelet aggregation].The long-term prognosis following acute coronary syndromes: a prospective observational study of unselected group treated in the 24/7 cardiac catheterization laboratory at university hospital.Risk factors for adverse outcomes of acute coronary syndrome patients - single center experience in long term follow-up of treated patients.Which components of the CHA2DS2-VASc score are the most important in obstructive sleep apnea patients with atrial fibrillation?Can continuous positive airway pressure therapy have antiarrhythmic properties?Occurrence of poor sleep quality in atrial fibrillation patients according to the EHRA score.Sleep duration in the first months after ST elevation myocardial infarction: an independent predictor of all-cause mortality.Clinical characteristics of patients with acute coronary syndrome at high clinical suspicion for obstructive sleep apnea syndrome.Prognostic value of troponin I and NT-proBNP concentrations in patients after in-hospital cardiac arrest.Diagnostic value of BNP in suspected perimyocarditis--a preliminary report.Serum B-Type natriuretic peptide in STEMI patients treated with PCI.Different ECG manifestations of left ventricular hypertrophy in presence of intermittent LBBB and RBBB.Clinical characteristics, aetiology and occurrence of type 2 acute myocardial infarction.Predykcja siedmioletniego ryzyka sercowo-naczyniowego: porównanie sześciu skal ryzyka u chorych z ostrym zespołem wieńcowym: GRACE, TIMI STEMI, TIMI NSTEMI, SIMPLE, ZWOLLE i BANACHAdmission ST-segment elevation in lead aVR as the factor improving complex risk stratification in acute coronary syndromesElectrocardiographic features and prognosis in acute diagonal or marginal branch occlusionPrognostic implications of myocardial necrosis triad markers' concentration measured at admission in patients with suspected acute coronary syndromeSerum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty[Apical ballooning syndrome in a 57-year-old woman during premedication for general anaesthesia][Three-dimensional echocardiography for the assessment of the efficacy of resynchronisation therapy in a patient with dilated cardiomyopathy and Sjögren's syndrome]Images in cardiovascular medicine. Drug-induced long-QT syndrome with macroscopic T-wave alternansPurulent pericarditis in patient with esophageal cancer presenting with cardiac tamponade
P50
Q33146186-72D1477B-C86F-4298-AE86-581613551BB1Q33196373-CBF02D98-61FA-4535-B9D0-B80F9D5AE8D5Q33501939-E46875B6-9D60-4042-A8B2-E5BC5FEFDD5FQ35597696-055301FA-918B-4D20-8420-E16D652E5D39Q37680488-7059DA3A-2CAF-49D3-A683-23BC82C451D9Q39185030-3C8E44DC-C30A-4501-89A3-EB7A339C6EB6Q39188994-7B685D76-B2ED-40BA-90D6-34586FD6AB2EQ39464667-3C1B33F3-5EA2-47B2-AFBE-2D8730A4CD18Q41048561-46830A53-F25B-479F-9C3D-9B2CDDD4E7C6Q41620649-DC5AA2AA-D95D-4A8D-A73E-5FB6A5AC0DC8Q41896951-F2C78DA9-73CF-49F6-8236-E0671DE94F70Q43446634-9631E85F-4201-42F4-A1C1-837535443612Q43454044-7EAB2A16-528B-46E4-8EF5-181EB1683D49Q43581143-331AC731-5C92-4F25-B2AC-7A1DDE9B0BCCQ43672135-37344694-C43F-405E-A9A3-101F74A1DF74Q43677392-9CEC0726-0C1F-4CE6-B298-9D04645EBF36Q44553766-81A63482-4512-4DA7-A8BF-A7E5E0E66DC2Q46353239-D8AEC858-195F-473E-B338-44610ED354C3Q46446326-B15D845C-8BB1-4168-8FC6-9768343E9038Q47177912-4B45BC9D-4EA5-4859-95EB-6C39B42B0249Q47723763-3CAFB367-6A4F-437B-BE4A-96A9895C6AD0Q47873164-4D1C4A86-78F7-4E7F-A12C-2E6DB236FE51Q47943893-186D5D1E-2729-44FE-BB30-354F1596D5C8Q48070702-9855BE04-F15D-48B9-8B64-081A48E77232Q48125841-6D313451-D1B6-46CF-B6EC-108279E84079Q48151472-661635D7-F529-403F-B4A2-52E6954C71C0Q48247882-B7E0A497-4DDA-482F-B125-9B6615E01774Q48893256-AD71A24E-C493-418A-922B-873484C02B65Q49122037-6C68F206-523F-452E-A655-955C8E35E8DAQ51026260-7A554777-98C2-407C-9AB1-8D01A5DFF4E1Q51191711-9BC715CF-38AE-4C95-86D6-28EE59860A50Q58841149-986669DD-A84C-426B-9C02-9350E10F0613Q58841211-7A5ED0C3-3F8C-44BD-BD0F-74A1D00C8147Q58841226-6FEDAFA0-9D9F-4242-875A-A88A71FF829CQ58841234-B1CB9243-0A3D-49EB-8E4E-B19F7CC1756CQ58841244-CC81938C-41F2-48B2-97BB-80E1D999E763Q79335280-E7ED72E7-D3AA-4549-B163-A476C42B339FQ80278279-5B5AE143-C863-4CF2-AE84-D8FC598962FCQ80946140-2EF10049-9A92-49CC-8BFC-55B98FCFE629Q83452134-D61CEBD7-A356-4C45-80FD-F568B94B05B0
P50
description
Forscher
@de
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究員
@ja
研究者
@zh
name
G Karpinski
@en
G Karpinski
@nl
type
label
G Karpinski
@en
G Karpinski
@nl
prefLabel
G Karpinski
@en
G Karpinski
@nl
P106
P31
P496
0000-0002-0094-0102